U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287839) titled 'Phase-2 Trial of Parcel-guided rTMS for Major Depressive Disorder' on Dec. 13.
Brief Summary: Study comparing standard repetitive transcranial magnetic stimulation (rTMS) for Depression to a novel targeting approach using brain surface parcellation to locate a specific brain target.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Treatment Resistant Depression (TRD)
Intervention:
DEVICE: Accelerated rTMS
rTMS targeting will be done using the standard Beam-F3 targeting method. Treatment will be delivered in an accelerated schedule with 50 treatment session over 5 days.
DEVICE: Parcel-guided Accelerated rTMS
r...